These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 31646605)

  • 1. Editorial - Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity.
    Infante M; Ricordi C
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8702-8704. PubMed ID: 31646605
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray.
    Woittiez NJ; Roep BO
    Immunotherapy; 2015; 7(2):163-74. PubMed ID: 25713991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.
    Lernmark Å; Larsson HE
    J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging Concepts on Disease-Modifying Therapies in Type 1 Diabetes.
    Greenbaum C; Lord S; VanBuecken D
    Curr Diab Rep; 2017 Oct; 17(11):119. PubMed ID: 29039056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-Specific Peptide Immunotherapy for Type 1 Diabetes: Proof of Safety, Hope for Efficacy.
    Coppieters K; von Herrath M
    Cell Metab; 2017 Oct; 26(4):595-597. PubMed ID: 28978425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies instead of insulin?].
    Anders S; Kühnemund L; Stauch M; Zündorf I; Dingermann T
    Pharm Unserer Zeit; 2010 Mar; 39(2):97-8. PubMed ID: 20196056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunotherapy of recent-onset type I diabetes mellitus].
    Assan R
    Ann Med Interne (Paris); 1985; 136(6):451-2. PubMed ID: 4083634
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy of type 1 diabetes mellitus.
    Chatenoud L
    Curr Dir Autoimmun; 2001; 4():333-50. PubMed ID: 11569410
    [No Abstract]   [Full Text] [Related]  

  • 9. Type 1 diabetes immunological tolerance and immunotherapy.
    Chentoufi AA; Geenen V; Giannokakis N; Amrani A
    Clin Dev Immunol; 2011; 2011():103738. PubMed ID: 22190967
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Autoimmune Diabetes: Molecular Mechanisms and Neoantigens.
    Kent SC; Zaldumbide A
    Front Immunol; 2022; 13():864517. PubMed ID: 35251056
    [No Abstract]   [Full Text] [Related]  

  • 11. Fighting the uphill battle to cure type 1 diabetes.
    Lee EY; Yoon KH
    J Diabetes Investig; 2021 Sep; 12(9):1542-1544. PubMed ID: 34110690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical review 17: Immunotherapy of type I diabetes mellitus.
    Marks JB; Skyler JS
    J Clin Endocrinol Metab; 1991 Jan; 72(1):3-9. PubMed ID: 1986025
    [No Abstract]   [Full Text] [Related]  

  • 13. Type 1 diabetes immunotherapy: is the glass half empty or half full?
    Herold KC; Bluestone JA
    Sci Transl Med; 2011 Aug; 3(95):95fs1. PubMed ID: 21832236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of type 1 diabetes.
    Li L; Yi Z; Tisch R; Wang B
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):227-36. PubMed ID: 18726144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination Immunotherapy for Type 1 Diabetes.
    Bone RN; Evans-Molina C
    Curr Diab Rep; 2017 Jul; 17(7):50. PubMed ID: 28534310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in immunotherapy of type I diabetes.
    Ni Q; Pham NB; Meng WS; Zhu G; Chen X
    Adv Drug Deliv Rev; 2019 Jan; 139():83-91. PubMed ID: 30528629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic treatment of autoimmune diabetes.
    Kim JH; Jin SM; Kim HS; Kim KA; Lee MS
    Crit Rev Immunol; 2013; 33(3):245-81. PubMed ID: 23756246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunointervention in type 1 diabetes mellitus].
    Vialettes B
    Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapies and immune biomarkers in Type 1 diabetes: A partnership for success.
    Rekers NV; von Herrath MG; Wesley JD
    Clin Immunol; 2015 Nov; 161(1):37-43. PubMed ID: 26122172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of insulin-dependent diabetes.
    Bell DS; Acton RT
    Ala J Med Sci; 1985 Jul; 22(3):311-4. PubMed ID: 4025722
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.